# Pfizer Inc. (PFE) — Q1-2017 Earnings Results

**Report date:** 2017-05-02 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q1-2017

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Down 0.5%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.69 | N/A | +1.19% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a cautious optimism regarding their earnings performance. They highlighted the importance of upcoming product developments.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite the lack of revenue details.

> The focus remains on future product pipelines and market strategies.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Pfizer's earnings report showed a slight beat on EPS, which is a positive sign for investors. However, the stock reacted negatively, dropping 0.5%. The lack of revenue information and guidance may have contributed to investor uncertainty.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q1-2017_